Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann H Partridge

Showing results (261-270 of 363) with videos related to

Pageof 37
Sort By:
Breast Cancer Research and Treatment|June 10, 2024
Second primary non-breast cancers in young breast cancer survivorsBessie X Zhang, Kristen D Brantley, Shoshana M Rosenberg, et al.
Future Oncology (London, England)|October 12, 2021
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancerCiara C O'Sullivan, Karla V Ballman, Linda McCall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.
Radiology|January 10, 2023
Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in SituDanalyn Byng, Samantha M Thomas, Christel N Rushing, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2016
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527Rachel A Freedman, Jared C Foster, Drew K Seisler, et al.
BMJ Open|July 1, 2024
Helping ourselves, helping others: the Young Women's Breast Cancer Study (YWS) - a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and youngerShoshana M Rosenberg, Yue Zheng, Kathryn Ruddy, et al.
Breast (Edinburgh, Scotland)|September 5, 2013
Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statementFatima Cardoso, Nuran Bese, Sandra R Distelhorst, et al.
BMC Medicine|January 6, 2016
Cancer and fertility preservation: international recommendations from an expert meetingMatteo Lambertini, Lucia Del Mastro, Maria C Pescio, et al.
Pageof 37

Showing results (261-270 of 363) with videos related to

Sort By:
Pageof 37
Breast Cancer Research and Treatment|June 10, 2024
Second primary non-breast cancers in young breast cancer survivorsBessie X Zhang, Kristen D Brantley, Shoshana M Rosenberg, et al.
Future Oncology (London, England)|October 12, 2021
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancerCiara C O'Sullivan, Karla V Ballman, Linda McCall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.
Radiology|January 10, 2023
Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in SituDanalyn Byng, Samantha M Thomas, Christel N Rushing, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2016
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527Rachel A Freedman, Jared C Foster, Drew K Seisler, et al.
BMJ Open|July 1, 2024
Helping ourselves, helping others: the Young Women's Breast Cancer Study (YWS) - a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and youngerShoshana M Rosenberg, Yue Zheng, Kathryn Ruddy, et al.
Breast (Edinburgh, Scotland)|September 5, 2013
Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statementFatima Cardoso, Nuran Bese, Sandra R Distelhorst, et al.
BMC Medicine|January 6, 2016
Cancer and fertility preservation: international recommendations from an expert meetingMatteo Lambertini, Lucia Del Mastro, Maria C Pescio, et al.
Pageof 37